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Abstract
Age-related hearing impairment (ARHI), or presbycusis, is a common condition of the elderly that
results in significant communication difficulties in daily life. Clinically, it has been defined as a
progressive loss of sensitivity to sound, starting at the high frequencies, inability to understand
speech, lengthening of the minimum discernable temporal gap in sounds, and a decrease in the
ability to filter out background noise. The causes of presbycusis are likely a combination of
environmental and genetic factors. Previous research into the genetics of presbycusis has focused
solely on hearing as measured by pure-tone thresholds. A few loci have been identified, based on a
best ear pure-tone average phenotype, as having a likely role in susceptibility to this type of
hearing loss; and GRM7 is the only gene that has achieved genome-wide significance. We
examined the association of GRM7 variants identified from the previous study, which used an
European cohort with Z-scores based on pure-tone thresholds, in a European–American
population from Rochester, NY (N = 687), and used novel phenotypes of presbycusis. In the
present study mixed modeling analyses were used to explore the relationship of GRM7 haplotype
and SNP genotypes with various measures of auditory perception. Here we show that GRM7
alleles are associated primarily with peripheral measures of hearing loss, and particularly with
speech detection in older adults.
© 2012 Elsevier B.V. All rights reserved.
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Age-related hearing impairment (ARHI or presbycusis) is one of the top three chronic
medical conditions of the aged, along with cardiovascular problems and arthritis (Dalstra et
al., 2005; Parmet et al., 2007). The genetics of this complex trait are just beginning to be
appreciated, with a significant interaction of genetic susceptibility and environmental
components (Cruickshanks et al., 2010). Although most, if not all, people lose hearing
acuity with age, empirical data have suggested that individuals have differing susceptibilities
to ARHI. A strong genetic component to susceptibility is evidenced by its high heritability
(approximately 50%) in twin and family studies (Christensen et al., 2001; Gates et al., 1999;
Karlsson et al., 1997; Wingfield et al., 2007). Environmental noise and ototoxic agents are
well known to influence hearing in old age, and hormones also influence susceptibility
(Guimaraes et al., 2006; Price et al., 2009; Tadros et al., 2005). Gender has long been
established as a major factor in hearing loss with age; men’s hearing tends to decline faster
and earlier than women’s (Dubno et al., 1997; Gates et al., 1999; Wiley et al., 2008). This is
likely due to both environmental factors and the influence of sex hormones on the auditory
system. For example, estrogen appears to be beneficial to preserving auditory function
(Kilicdag et al., 2004; Kim et al., 2002).
Early studies addressing the genetic basis of ARHI in humans led to the identification of a
voltage-gated potassium channel (KCNQ4, OMIM ID: 603537) (Van Eyken et al., 2006)
and N-acetyltransferase 2 (NAT2*6A, OMIM ID: 612182) (Unal et al., 2005; Van Eyken et
al., 2007) as possible susceptibility genes. In one study, about 40 different candidate genes
were tested based on their association with Mendelian forms of hearing loss; the most
significant association was within an intron of the grainyhead-like 2 gene (GRHL2, OMIM
ID: 608576) (Van Laer et al., 2008). Several linkage studies were attempted, but they either
failed to identify any genome-wide significant peaks or exhibited such broad peaks that it
was impossible to identify specific causative genes or mutations (DeStefano et al., 2003;
Garringer et al., 2006; Huyghe et al., 2008).
A 500K-single nucleotide polymorphism (SNP) genome-wide association study of a large
European cohort of older adults (Study 1) resulted in the identification of one haplotype
within the glutamate metabotrophic receptor 7 (GRM7, OMIM ID: 604101) as harboring a
significant risk allele for ARHI (Friedman et al., 2009). Friedman et al. also reported
another, smaller, study (study 2), in which the locus was fine-mapped and confirmed in a
second European cohort. Using two different genetic analysis methods, either a single
intronic SNP or the adjacent haplotype block, showed the strongest signal in these two
samples. GRM7 is thought to be central to maintaining glutamate synaptic transmission and
homeostasis in the mammalian cochlea at the synapses between hair cells and the dendrites
of afferent auditory nerve fibers. The presence of glutamate in excessive quantity has been
suggested as a mechanism mediating neurotoxicity in auditory neurons (Pujol et al., 1990).
In the paper describing the original GRM7–ARHI association (Friedman et al., 2009), three
genetic factors were described: a single SNP (rs11928865), and two haplotypes (Blocks 6 &
7). SNPs are identified when the sequence of a single nucleotide (T, A, G, C) within a
genome differs among individuals. This difference in DNA sequence may result in
differences in the expression of proteins encoded by the gene, which may be related to a
disease or other phenotypic aspect. Haplotype blocks are groups of SNPs that tend to be
inherited together or “travel together” over successive generations. SNP rs11928865 falls
within haplotype block 6, adjacent to haplotype block 7, and both haplotype blocks are
found within intron 2 of the GRM7 gene on chromosome 3. Given that there is no principled
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method by which SNP or haplotype information may be selected as the best indicator of the
GRM7 gene, we used both the haplotype and SNP definitions in the analyses.
No single measure captures the rich variety of hearing capacities in the auditory system.
Clinically, pure-tone thresholds (PTs) are used to provide a “bird’s eye view” of the basic
level of hearing sensitivity (Fitzgibbons and Gordon-Salant, 1996; Frisina and Frisina, 1997;
Schmiedt, 2010; Helfer and Vargo, 2009). Accurate measurement of pure-tone thresholds is
dependent upon the alertness, cognitive and motoric abilities, and cooperation of the
individual. Pure-tone thresholds are measured separately for each ear, in quiet, and at eight
different frequencies (ranging from 0.25 to 8 kHz). The individual must push a button, raise
a hand, or give verbal response to a tone in order to determine the quietest sound at which a
frequency may be detected. The frequencies are chosen to test sounds in the speech range
and, since the cochlea is tonotopically arranged, a sampling of frequencies will test the
cochlea’s function from base to apex. This clinical assessment of hearing results in eight
measurements (each ear) or 16 data points for a single individual.
Pure-tone thresholds do not provide information about how well an individual can recognize
speech or perceive speech (words or sentences). Further, the results of hearing tests
conducted in quiet are often quite different than when that same test is conducted in noise.
An individual who appears to have a normal audiogram (thresholds) may be impaired in a
noisy situation, such as many older adults, who have difficulty understanding speech in the
presence of background noise (Schneider et al., 2010). Hearing speech in noise performance
may be more related to brainstem and auditory cortex functioning (Humes and Dubno,
2010), than strictly a product of end organ transduction. The complexity of measuring
hearing increases with age, as discrete biological processes which combine to produce
efficient speech processing may de-couple and, further, may have different trajectories over
time (Birren and Fisher, 1991; Park and Reuter-Lorenz, 2009).
Given the complexity of measuring hearing and the clinical availability of pure-tone
thresholds, the usual manner in which the aging phenotype has been defined has been to use
pure-tone thresholds (e.g., ISO 7029; Acoustical Society of America, 1998). Methods to
quantify the phenotype of ARHI have included a variety of statistical transformations of
threshold data in order to reduce the dimensionality of the data set. Transformations of the
data have included averaging across frequencies solely for the better ear, normalizing the
average thresholds, principal components analysis, and Z-scores (age/sex-adjusted normally
distributed data; Fransen et al., 2004). Each of these approaches defined ARHI using only
derivations of PTs, despite the known complexity of the aging auditory system.
The ARHI phenotype associated with the GRM7 SNP rs11928865 (Friedman et al., 2009)
was defined through using separate male and female Z-score transformations of the better
ear’s pure-tone average (PTA) at 2, 4, and 8 kHz, partialed for age. The Z-score, termed
“high frequency” in the Friedman et al. paper, represented the distance from the median
average threshold for males and females separately. Cases, or those subjects showing the
effects of ARHI, were selected from both male and female distributions and showed a
positive Z-score (poorer hearing than the median). Controls were selected from those
showing a negative Z-score (better hearing than the median).
This methodology for selecting cases and controls is an effective approach when the
underlying trait is more or less isomorphic with the measure used and the study design is a
genome-wide association study. However, the Friedman et al. (2009) method separates older
adults solely on their ability to hear high tones and does not address other aspects of the
aging auditory system, such as aging effects on the other parts of the cochlea or speech
understanding. The present data set and experimental design are uniquely positioned to
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provide supporting evidence for the association of GRM7 genotypes with various measures
of the aging auditory system more generally.
Age and gender effects can be modeled with genotype information in a battery of hearing
measures, instead of using a single measure to create cases and controls. Several tests have
been developed to assess human subjects for aspects of speech and temporal processing
abilities that are localized to the central auditory system rather than just the cochlea. For
example, the Hearing-in-Noise Test (HINT) is an assay of supra-threshold speech
recognition in background noise, with components of spatial hearing abilities assessment
(spatial release from masking). Supra-threshold gap detection tasks are also useful as
measures of temporal features of the auditory system (Gordon-Salant and Fitzgibbons, 2001;
Mazelová et al., 2003; Pichora-Fuller and Souza, 2003; Pichora-Fuller et al., 2007).
We chose mixed modeling techniques to appropriately analyze the dependencies inherent in
multiple data points within PT data (Hox, 2010, Singer and Willett, 2003; West et al., 2007)
and the hearing measures with data for each ear. Mixed modeling is an especially attractive
technique for repeated measures designs and has moved from the domain of the specialist to
a myriad of applications from medicine to sociology to economics (Hox, 2010). In essence,
the dependencies in the repeated measures are modeled in the repeated level of analysis,
leading to appropriate estimates of the fixed effects, here GRM7 genotypes. The present
investigation tested untransformed, or raw, PTs for both ears and measures related to speech
perception to test for an association, or a statistically significant relationship, with GRM7
genotypes.
The data analysis proceeded in two steps in order to determine if an effect of GRM7
genotype could be detected on the hearing test results. At each step, we treated hearing
variables as fully continuous variables and did not categorize a subset of subjects into cases
or controls. The use of the hearing variables as continuous variables allowed an examination
of the effects of GRM7 across a typical older adult population, whether the individual’s
hearing fell into a pre-defined category of showing ARHI or not.
First, analysis of covariance (ANCOVA) on “high frequency” (2, 4, 8 kHz) PTA for the
better ear was used to examine the relationship of the single SNP and two haplotypes
detected in the Friedman et al. (2009) work. The purpose of this step was to determine the
effect of GRM7 alleles, if any, in the present sample using different statistical methods, but
keeping to the same underlying measurement (high PTs). The ANCOVA allows for the
possibility of detecting an interaction between a GRM7 genotype, gender, and age at hearing
test, on better ear PTA, something not possible with the previous design and analysis. This
first analysis is not a replication of the Friedman et al. study, because we did not conduct the
transformations as in the original paper, but supporting analyses to explicitly model
relationships assumed in the previous work’s data transformations and to gain a sense of the
size of the genotype effect, if any. Second, mixed model analyses were carried out,
beginning with more completely exploring the possible effects of GRM7 genotype on all the
pure-tone thresholds at the eight clinically assessed frequencies across each ear and
including additional measures of hearing in the test battery.
The study had two objectives: (1) to determine the relationship, if any, between GRM7
haplotype or SNP allele and high frequency PTA in a well-described older adult sample, and
(2) if a relationship holds, to test for a relationship in the additional hearing measures. If no
relationship was found, then the basic work to determine the pathways in the auditory
system impacted by GRM7 would be of less interest. If a relationship was detected, then
further work on the molecular pathways involving GRM7 in the auditory system would be
indicated.
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2. Material and methods
2.1. Study subjects
The study cohort consisted of 687 individuals (59% female) from the Rochester, NY greater
metropolitan area, all of whom provided informed consent for their inclusion in the study.
All subjects were white, over the age of 58 years (mean 71.3 ± 7.3 y) and not related to any
other subject in the study. Subjects donated a blood or buccal cell sample at the time of
testing. Health and family histories were recorded. Individuals with the following conditions
were excluded: conductive hearing loss (assessed by comparison of air conduction with
bone conduction), severe head injury, labyrinthitis, mastoiditis, Meniere’s disease, multiple
sclerosis, neuropathy, dementia, stroke, history of seizures, hereditary hearing loss, ear
infections, extensive noise exposure (self-report), and known ototoxic drug exposure.
2.2. Audiological phenotype tests
Volunteers from the Rochester cohort were paid $40 for participation in a 4-h audiometric
testing session, using protocols approved by both the Rochester Institute of Technology and
University of Rochester Institutional Review Boards. The hearing tests included standard
audiometric characterizations: pure-tone air conduction thresholds (0.25, 0.5, 1, 2, 3, 4, 6, 8
kHz) and bone conduction thresholds (0.5, 1, 2, 4 kHz), tympanometry to assess middle ear
status/function, and speech reception thresholds (SRT). Additional testing included supra-
threshold gap detection (a measure of temporal processing, presented at sound levels audible
to all subjects) and HINT free-field speech-in-noise testing. The HINT results were analyzed
using the release from masking (RFM) signal-to-noise ratio, thought to be a measure of
binaural processing (Soli and Wong, 2008). These methods have been described in detail
previously (Frisina et al., 2006; Guimaraes et al., 2006; Nilsson et al., 1994; Tadros et al.,
2005). Table 1 shows the auditory test battery mean results in the Rochester cohort.
2.3. Genotyping
Genomic DNA was extracted from blood or buccal samples using the Gentra®
PUREGENE® kit (now supplied by Qiagen). Genotyping of five GRM7 SNPs (numbered in
sequential order on the chromosome: GRM7-1 = rs11928865, GRM7-2 = rs9877154,
GRM7-3 = rs3828472, GRM7-4 = rs9819783, GRM7-5 = rs11920109) was performed on
DNA samples from all subjects using Pre-Designed TaqMan® SNP Assays from Applied
Biosystems™ with an Applied Biosystems™ 7500 Real-Time PCR instrument under
standard conditions. Random samples corresponding to each genotype were verified by
direct sequencing using the BigDye® Terminator v3.1 Cycle Sequencing Kit from Applied
Biosystems. All five SNPs were found to be in Hardy–Weinberg Equilibrium using the
online “Hardy–Weinberg equilibrium calculator including analysis for ascertainment bias”
(Rodriguez et al., 2009). Haplotypes were constructed from individual genotypes with the
program PHASE (Stephens et al., 2001). Haplotype block 6 was constructed from
rs11928865 and rs9877154, while haplotype block 7 was constructed from rs3828472,
rs9819783 and rs11920109 (see Table 2). The allele frequencies of all five GRM7 SNPs are
shown in Table 2 and the haplotype frequencies are in Table 3. Since GRM7 block 7
haplotypes CTT, ATT, ACT and ACC counts made up 99% of the sample, the other
haplotypes were omitted from analyses.
2.4. Association of genotype and phenotype: statistical methods
“High frequency” PTA (HPTA) was calculated as a mean of the PTs at 2, 4, and 8 kHz. The
speech intelligibility index (SII) was calculated using the PTs from each ear, using ANSI
S3.5-1997 methodology (Acoustical Society of America, 1998). Not all subjects were able
to detect the gap in noise, as evidenced by greatly lengthened detection responses (greater
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than 10 s, see (Snell, 1997). The best gap detection time of the two repetitions at each
frequency (1 and 4 kHz) was used in the analyses and any response greater than 10 s was
coded as missing. In addition, not all subjects could complete the HINT test. Any noise
composite score signal-to-noise ratio of greater than 0.0 (representing poor performance for
normal hearers; Vermiglio, 2008) was coded as missing.
As noted above, the first step was to determine if the GRM7 genotypes significantly differed
on HPTA for the better ear, with age at hearing test and gender as covariates. The interaction
of genotype and gender was also added (full model). Second, the full model of fixed effects
was estimated for the two haplotypes and the rs11928865 allele for each hearing measure:
PTs, SRT, SII, Gap Detection and HINT RFM (n = 15 separate analyses). The full or
saturated model was estimated first using maximum likelihood (Harrell, 2010; Hox, 2010,
Singer and Willett, 2003; West et al., 2007) and significant interactions were decomposed
with univariate analyses. All analyses were conducted in SPSS® 19.0, with statistical
significance set at alpha <0.05.
The statistical hypothesis of interest is the test of a main effect of GRM7 allele in each of the
five dependent variables. Given that each dependent variable was examined for this main
effect three times (one for each GRM7 genotype), a Bonferroni correction was made to the
alpha level for the main effect of GRM7 allele. Thus, the significance level for the main
effect of GRM7 in each analysis was computed as 0.05/3 = 0.017.
3. Results
The test sample included subjects with a wide range of hearing abilities, from those with
excellent hearing for their age to those with severe hearing loss. On average, as shown in
Fig. 1, females had better PT values than males and on average there was no strong
advantage of one ear over the other; that is, most subjects had symmetrical hearing.
3.1. GRM7 association with ARHI in the Rochester cohort
3.1.1. High frequency pure-tone threshold average, better ear—An ANCOVA
was conducted with each haplotype and rs11928865 genotype, with gender as a factor (male,
female) and age as a continuous covariate. For each ANCOVA, age was a significant
covariate (each p < 0.0001) and gender was a significant main effect (each p < 0.0001).
Haplotype block 6 and 7 genotypes, and the rs11928865 genotype did not reach significance
as a main effect (each p > 0.017) or interaction with gender (each p > 0.017). It appears that
the best ear HPTA is not associated with GRM7.
3.1.2. Pure-tone threshold, both ears, eight frequencies—A saturated mixed
model of pure-tone threshold by frequency and ear as repeated variables, with frequency,
gender and age as fixed effects was conducted with each of the GRM7 haplotype groups and
the rs11928865 genotype. Three mixed model analyses were carried out.
Age, frequency, and gender were significant fixed effects (each p < 0.0001) for all three
GRM7 genotype analyses. The gender by frequency interaction was significant (each p <
0.0001) for all three GRM7 genotype analyses. There were significant fixed effects of each
GRM7 genotype (Haplotype 6, p < 0.0001, Haplotype 7, p < 0.0001, rs11928865, p <
0.015). Each of those p-values was less than the Bonferroni correction alpha value of 0.017.
The interaction between haplotype block 6 and gender was not significant (p = 0.05), but
there was a significant interaction between haplo-type block 7 and gender (p < 0.0001, see
Fig. 2). There were no other significant effects.
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A mixed model of the PT by age and haplotype block 7 was conducted for males and
females separately, in order to understand the interaction of haplotype block 7 and gender.
There was a main effect of haplotype block 7 (each p < 0.0001) for both the males and
females, indicating that haplotype block 7 was significantly associated with PT within each
gender. However, pairwise comparisons showed a complex relationship between genotype
within gender, rendering the search for a risk allele within males and females difficult.
Pairwise comparisons of the haplotype block 7 genotype within females showed that CTT/
CTT and CTT/ACT had significantly better hearing than ATT/ATT (each p < 0.0001).
Within the males, genotype CTT/CTT and CTT/ACT were among the five poorest hearing
genotypes (each p < 0.001). However, ATT/ATT genotype average threshold in the males
was significantly poorer than the best hearing groups (p < 0.01), but not different from the
poorest hearing groups. The data did not show any simple pattern of differences by gender.
3.1.3. Speech reception threshold, both ears—A saturated mixed model of SRT by
ear as the repeated variable, with gender and age as fixed effects was conducted with each of
the GRM7 haplotype blocks and the rs11928865 genotype. Three mixed model analyses
were carried out. Age was significant across all three analyses (p < 0.001), but gender was
not. The rs11928865 genotype was not significant, haplotype blocks 6 (p < 0.021) and 7 (p <
0.0 13) were nominally significant effects, but only the haplo-type block 7 main effect was
less than the Bonferroni corrected p-value 0.017. No interaction was significant in any of the
three analyses.
Pairwise comparisons among the haplotype block 6 genotypes showed that the TT/TT
genotype tended to have the poorest average SRT relative to the other genotypes (see Fig.
3). Pairwise comparisons among the haplotype block 7 genotypes showed that CTT/CTT
group tended to have the better SRT and ATT/ATT group tended to have the poorer SRT
(see Fig. 3).
3.1.4. Speech intelligibility index (SII), both ears—A saturated mixed model of SII
by ear as the repeated variable, with gender, PTA, and age as fixed effects was conducted
with each of the GRM7 haplotypes and the rs11928865 genotype. Pure-tone average (PTA)
was included in this analysis to control for differences in hearing level influencing the SII.
Three mixed model analyses were carried out.
Age, PTA, and gender were significant main effects in all three analyses (each p < 0.01).
There were no significant effects of the haplotype groups or rs11928865 genotype. There
were no significant interactions in all three analyses.
3.1.5. Gap detection at 1 and 4 kHz—A saturated mixed model of Gap Detection by
Frequency (1 and 4 kHz) as the repeated variable, with age as fixed effect was conducted
with each of the GRM7 haplotype groups and the rs11928865 genotype. Three mixed model
analyses were carried out. Age was a significant main effect in the analysis of haplotype
block 6 and the rs11928865 genotype (each p < 0.01), but did not achieve significance in the
analysis of haplotype block 7 (p = 0.053). There were no significant effects of the haplotype
or single SNP genotype. There were no significant interactions in all three analyses.
3.1.6. HINT release from masking by side—A saturated mixed model of RFM by ear
as the repeated variable, with age as fixed effect was conducted with each of the GRM7
haplotype blocks and the rs11928865 genotype. Three mixed model analyses were carried
out. Age was a significant main effect for both haplotypes and the single SNP genotype
(each p < 0.001). Gender was a significant main effect across all three analyses (each p <
0.004). There were no significant effects of the haplotype or single SNP genotype. There
were no significant interactions in all three analyses.
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The results from the Rochester subject population show that GRM7 is significantly
associated with PT (individual thresholds across the ears) and SRT. Previous research had
suggested a GRM7 association with ARHI, as defined by Z-score better ear PTA (partialed
for age and gender) in older adults. The present study has shown an association of GRM7
with SRT in older adults in addition to a comprehensive evaluation of PT. This is the first
investigation of genetic associations with measures of speech detection, supporting the role
of GRM7 contributing to age-related hearing loss.
The present study is significant because it supports the finding of GRM7 association with
ARHI (Friedman et al., 2009), and particularly with haplotype blocks 6 and 7. The Z-score
used in the original study (Friedman et al., 2009) was similar to the HPTA phenotype used
here; however, the Z-score method used age and gender in the calculation of the dependent
value, whereas we used age and gender as covariates in the analysis. This difference in
methodology likely contributes to our lack of a significant main effect of GRM7 on the
HPTA. In addition, the previous genome-wide study looked at the extreme ends of the PTA
distribution, creating “cases and controls”. In contrast, this study was able to take advantage
of the entire sample, treating HPTA as a continuous variable.
Another GRM7 geno-phenotype study, on the Finnish Saami population, found association
of a SNP downstream of GRM7 with a principal component highly correlated with the Z-
score of pure-tones (Van Laer et al., 2010). The presence of a different allele near the same
gene in a historically isolated population is evidence of genetic heterogeneity as well as
support for the importance of GRM7 in ARHI. Our procedure allowed for the explicit
assessment of the respective contribution of age and gender to observed variability in
auditory performance. The process of creating phenotype values based on age- and sex-
conditioned distributions presumes, without statistically testing that hypothesis, a significant
relationship of age and gender to the hearing phenotype. This analytic process also does not
allow for testing for the interaction effects of age and sex, the process presumes that the
interaction estimate is zero. These are strict assumptions, which are not likely to hold in
larger data sets, indeed, it was not supported in this data set. In contrast, we were able to test
those associations explicitly. We discovered that the interaction of gender and genotype was
significant for thresholds across frequencies and ear, suggesting that the pattern of GRM7
genotypes is different for women and men across age. This finding could not be detected
using age- and sex-adjusted Z-scores of the previous investigations.
This study revealed that GRM7 is not only associated with PT by frequency, but also SRT, a
measure of hearing that has not been previously examined. The association of GRM7 with
SRT indicated a genetic association with aspects of speech detection. Speech detection
deficits and PT elevations detract significantly from productivity, real-world quality of life,
and psychological well-being for elderly people. Further research is indicated to understand
the implications of the GRM7 association with pure-tone thresholds and SRT.
Presbycusis is a highly prevalent communication problem for the majority of people over 65
years of age. Due to possible hormonal and gene/environment interactions, on average, older
men are more severely affected than older women (Schmiedt, 2010), as was observed in the
present subject sample (see Fig. 1). The percentage of the population affected by this
ailment will increase in the near future even if there is no change in average lifespan. Given
that the average lifespan may still increase, prevention of, slowing down the progression of,
and/or treatment of ARHI comprise major scientific and translational medicine efforts. The
ability to hear is frequently taken for granted until one suffers from hearing loss, and hearing
losses in old age can prove to be a difficult adaptation process, resulting in communication
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difficulties at work and at home, leading to psychological problems and depression (Hogan
et al., 2009). The findings of the present investigation are consistent with observations that
genetics and environment interact in older individuals, linking age-related hearing loss to
other neurodegenerative risk factors, including brain, cognitive and sensory functions
declines (Lin, 2011; Lin et al., 2011).
Recent advances in the ability to assay hundreds of thousands of genetic variations in many
individuals with high throughput techniques have allowed for the identification of
susceptibility genes for specific diseases. Fundamental to these advances has been the
discovery of reproducible quantitative traits. For many diseases, these measurements may
have natural variation and fluctuations that increase the variability of the data obtained.
ARHI is an ideal sensory deficit for these types of analyses due to the relatively stable,
quantitative measurement of hearing loss, including determination of pure-tone and speech
thresholds and supra-threshold hearing measures.
The human auditory system is a multi-component system that involves physical detection of
the acoustic signal in the inner ear, processes to filter and amplify this signal, mechanisms to
convert this signal into the code of the nervous system (action potentials), propagation of
sound information to the brain, and then finally, interpretation by the regions of the central
nervous system used for sound perception and sensory integration. Keeping the basic
structure of the auditory system in mind, a primary goal is to derive a battery of maximally
useful audiological tests and to use statistical analysis of the resulting data to quantitatively
define hearing status for genetic analyses. Several decades ago, a research team headed by
Schuknecht examined pure-tone audiometric data and suggested that ARHI was actually an
umbrella diagnosis capturing up to four distinct etiologies within its diagnosis (Schuknecht,
1953, 1964, 1993; Schuknecht and Gacek, 1993). The usefulness of Schuknecht’s approach
to understanding the possible biological bases of presbycusis underlies the importance of
utilizing a previously unprecedented, comprehensive battery of classic and experimental
auditory tests for phenotypic characterization in the present investigation.
Any genetic analysis that solely uses threshold data to assess ARHI is bound to suffer from a
reduction in power due to genetic heterogeneity. One approach to reducing this
heterogeneity is to use broad test batteries of hearing ability to identify different sources of
variability in data sets. Towards this goal, we collected a large cohort of aged individuals
(average age 71 y), and then subjected them to an extensive battery of audiometric tests.
These tests address different aspects or levels of the auditory system and can be used to
identify groups of patients sharing similar phenotypic test results.
Finally, we showed that men and women have differing susceptibility to ARHI depending
on their GRM7 genotypes. The mechanism of this gender interaction with PT is unknown,
but it could be important in a clinical context. Future work investigating whether sex
hormones directly or indirectly affect glutamate synaptic transmission in the cochlea is
needed.
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ANCOVA analysis of covariance
ANOVA analysis of variance
ARHI age-related hearing impairment
GRM7 glutamate metabotropic receptor 7 gene
HINT hearing in noise test
HPTA high frequency pure tone average
PCR polymerase chain reaction
PT pure tone threshold (air conduction)
PTA pure tone average
RFM release from masking
SII speech intelligibility index
SNP single nucleotide polymorphism
SRT speech reception threshold
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Pure-tone thresholds by test frequency and gender for all subjects (n = 687).
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Average pure-tone threshold by gender and haplotype block 7 (standard error of the mean).
The haplotypes are ordered by average threshold for the males. Note the genotype CTT/
CTT: the females had the best hearing but the males had the poorest hearing.
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Average speech reception threshold (dB, standard error of the mean) by haplotype block 6.
Groups are ordered by average.
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Table 2
Allele frequencies of GRM7 SNPs.
SNP ID number Alleles (p, q)a Minor allele frequency Haplotype block
rs11928865 C, T 0.48 6
rs9877154 T, A 0.28 6
rs3828472 A, C 0.31 7
rs9819783 T, C 0.44 7
rs11920109 T, C 0.37 7
a
p, Major allele; q, minor allele.
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